Анализ структурных изменений в гомологах белка MutL системы "мисматч"-репарации, приводящих к возникновению онкологических заболеванийкурсовая работа (Бакалавр)
Аннотация:1. No similar oncogenic mutations in genes of MLH1, PMS2 and PMS1 in patients with bladder cancer, melanoma or glioma were found.
2. The probability of occurrence of studied oncogenic diseases doesn’t exceed 6%. Therefore, it’s unlikely that 100% holding of mutation in TERT promotor is related to mutations in MutL genes.